Adult vaccination coverage in the United States: A database analysis and literature review of improvement strategies

Hum Vaccin Immunother. 2024 Dec 31;20(1):2381283. doi: 10.1080/21645515.2024.2381283. Epub 2024 Jul 30.

Abstract

Despite vaccines being instrumental in reducing vaccine-preventable disease, adult vaccination rates in the United States (US) are below optimal levels. To better understand factors affecting vaccination rates, we analyzed trends in adult vaccination coverage using data from the Behavioral Risk Factor Surveillance System (BRFSS) and conducted a targeted literature review (TLR) on interventions to improve adult vaccination rates in the US. Both the BRFSS analysis and the TLR focused on influenza; pneumococcal disease; tetanus and diphtheria or tetanus, diphtheria, and acellular pertussis; herpes zoster; and human papillomavirus vaccination for US adults aged 18-64 years. The TLR additionally included hepatitis A and hepatitis B vaccination. Vaccination coverage rates (VCRs) and changes in VCRs were calculated using the 2011-2019 BRFSS survey data. For the TLR, the MEDLINE and MEDLINE In-Process databases were searched for articles on vaccination interventions published between January 2015 and June 2021. The BRFSS analysis showed that changes in VCRs were generally modest and positive for most states over the study period. The TLR included 32 articles that met the eligibility criteria; intervention strategies that improved adult vaccination outcomes incorporated an educational component, vaccination reminders or reinforcement at the point of care, or authorized non-clinician members of the healthcare team to vaccinate. Furthermore, interventions combining more than one approach appeared to enhance effectiveness. The strategies identified in this TLR will be valuable for policymakers and stakeholders to inform the development and implementation of evidence-based policies and practices to improve adult vaccination coverage.

Keywords: Adult; health policy; immunization; vaccination programs; vaccinations.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Behavioral Risk Factor Surveillance System
  • Databases, Factual
  • Female
  • Humans
  • Immunization Programs / statistics & numerical data
  • Influenza Vaccines / administration & dosage
  • Male
  • Middle Aged
  • United States
  • Vaccination / statistics & numerical data
  • Vaccination Coverage* / statistics & numerical data
  • Vaccine-Preventable Diseases / prevention & control
  • Young Adult

Substances

  • Influenza Vaccines

Grants and funding

This work was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD). RTI Health Solutions, an independent nonprofit research organization, received funding under a research contract with MSD to conduct this study and provide publication support in the form of manuscript writing, styling, and submission. Authors from MSD were involved in the study as disclosed in the Contributors subsection. The content is the sole responsibility of the authors and does not necessarily represent the official views of MSD or RTI Health Solutions.